ViTaL: A Multimodality Dataset and Benchmark for Multi-pathological Ovarian Tumor Recognition

TL;DR

This paper introduces ViTaL, a comprehensive multimodal dataset and a novel neural network model for multi-pathological ovarian tumor recognition, significantly advancing early diagnosis capabilities.

Contribution

The paper provides the first multimodal dataset for ovarian tumor classification and proposes ViTaL-Net with THOAM for effective multi-pathology recognition.

Findings

Achieved over 90% accuracy on common ovarian tumor types

Overall classification accuracy reached 85%

Demonstrated effectiveness of multi-modal data fusion

Abstract

Ovarian tumor, as a common gynecological disease, can rapidly deteriorate into serious health crises when undetected early, thus posing significant threats to the health of women. Deep neural networks have the potential to identify ovarian tumors, thereby reducing mortality rates, but limited public datasets hinder its progress. To address this gap, we introduce a vital ovarian tumor pathological recognition dataset called \textbf{ViTaL} that contains \textbf{V}isual, \textbf{T}abular and \textbf{L}inguistic modality data of 496 patients across six pathological categories. The ViTaL dataset comprises three subsets corresponding to different patient data modalities: visual data from 2216 two-dimensional ultrasound images, tabular data from medical examinations of 496 patients, and linguistic data from ultrasound reports of 496 patients. It is insufficient to merely distinguish between benign and malignant ovarian tumors in clinical practice. To enable multi-pathology classification of ovarian tumor, we propose a ViTaL-Net based on the Triplet Hierarchical Offset Attention Mechanism (THOAM) to minimize the loss incurred during feature fusion of multi-modal data. This mechanism could effectively enhance the relevance and complementarity between information from different modalities. ViTaL-Net serves as a benchmark for the task of multi-pathology, multi-modality classification of ovarian tumors. In our comprehensive experiments, the proposed method exhibited satisfactory performance, achieving accuracies exceeding 90\% on the two most common pathological types of ovarian tumor and an overall performance of 85\%. Our dataset and code are available at https://github.com/GGbond-study/vitalnet.